Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jerome Avouac

Showing results (11-20 of 57) with videos related to

Pageof 6
Sort By:
Arthritis Research & Therapy|May 31, 2015
Combined effect of genetic background and gender in a mouse model of bleomycin-induced skin fibrosisNadira Ruzehaji, Jerome Avouac, Muriel Elhai, et al.
Annales De Cardiologie Et D'Angeiologie|May 26, 2026
[Correlation between carotid atheroma and DAS28 gamma GT score in rheumatoid arthritis in an African black population]Dieu-Donné Ouédraogo, Taryetba André Arthur Seghda, Fulgence Kabore, et al.
Clinical and Experimental Rheumatology|September 6, 2018
From VEDOSS to established systemic sclerosis diagnosis according to ACR/EULAR 2013 classification criteria: a French-Italian capillaroscopic surveyMassimiliano Vasile, Jerome Avouac, Iliana Sciarra, et al.
Annals of the Rheumatic Diseases|March 11, 2016
Pan PPAR agonist IVA337 is effective in prevention and treatment of experimental skin fibrosisNadira Ruzehaji, Camelia Frantz, Matthieu Ponsoye, et al.
The Journal of Rheumatology|August 17, 2013
Combination of echocardiographic and pulmonary function test measures improves sensitivity for diagnosis of systemic sclerosis-associated pulmonary arterial hypertension: analysis of 2 cohortsHeather Gladue, Virginia Steen, Yannick Allanore, et al.
Annals of the Rheumatic Diseases|April 26, 2011
The transcription factor JunD mediates transforming growth factor {beta}-induced fibroblast activation and fibrosis in systemic sclerosisKatrin Palumbo, Pawel Zerr, Michal Tomcik, et al.
Annals of the Rheumatic Diseases|August 13, 2017
Pan-PPAR agonist IVA337 is effective in experimental lung fibrosis and pulmonary hypertensionJerome Avouac, Irena Konstantinova, Christophe Guignabert, et al.
Annals of the Rheumatic Diseases|January 22, 2015
Tribbles homologue 3 stimulates canonical TGF-β signalling to regulate fibroblast activation and tissue fibrosisMichal Tomcik, Katrin Palumbo-Zerr, Pawel Zerr, et al.
The Journal of Rheumatology|January 30, 2010
Association of metalloproteinase gene polymorphisms with systemic sclerosis in the European Caucasian populationJulien Wipff, Philippe Dieude, Jerome Avouac, et al.
Joint Bone Spine|March 26, 2026
Clinical and Pharmacological Outcomes After Switching from Intravenous to Subcutaneous Infliximab in Chronic Inflammatory Rheumatic DiseasesOlivier Fogel, Cécile Bottois, Marie Laure Tourneur, et al.
Pageof 6

Showing results (11-20 of 57) with videos related to

Sort By:
Pageof 6
Arthritis Research & Therapy|May 31, 2015
Combined effect of genetic background and gender in a mouse model of bleomycin-induced skin fibrosisNadira Ruzehaji, Jerome Avouac, Muriel Elhai, et al.
Annales De Cardiologie Et D'Angeiologie|May 26, 2026
[Correlation between carotid atheroma and DAS28 gamma GT score in rheumatoid arthritis in an African black population]Dieu-Donné Ouédraogo, Taryetba André Arthur Seghda, Fulgence Kabore, et al.
Clinical and Experimental Rheumatology|September 6, 2018
From VEDOSS to established systemic sclerosis diagnosis according to ACR/EULAR 2013 classification criteria: a French-Italian capillaroscopic surveyMassimiliano Vasile, Jerome Avouac, Iliana Sciarra, et al.
Annals of the Rheumatic Diseases|March 11, 2016
Pan PPAR agonist IVA337 is effective in prevention and treatment of experimental skin fibrosisNadira Ruzehaji, Camelia Frantz, Matthieu Ponsoye, et al.
The Journal of Rheumatology|August 17, 2013
Combination of echocardiographic and pulmonary function test measures improves sensitivity for diagnosis of systemic sclerosis-associated pulmonary arterial hypertension: analysis of 2 cohortsHeather Gladue, Virginia Steen, Yannick Allanore, et al.
Annals of the Rheumatic Diseases|April 26, 2011
The transcription factor JunD mediates transforming growth factor {beta}-induced fibroblast activation and fibrosis in systemic sclerosisKatrin Palumbo, Pawel Zerr, Michal Tomcik, et al.
Annals of the Rheumatic Diseases|August 13, 2017
Pan-PPAR agonist IVA337 is effective in experimental lung fibrosis and pulmonary hypertensionJerome Avouac, Irena Konstantinova, Christophe Guignabert, et al.
Annals of the Rheumatic Diseases|January 22, 2015
Tribbles homologue 3 stimulates canonical TGF-β signalling to regulate fibroblast activation and tissue fibrosisMichal Tomcik, Katrin Palumbo-Zerr, Pawel Zerr, et al.
The Journal of Rheumatology|January 30, 2010
Association of metalloproteinase gene polymorphisms with systemic sclerosis in the European Caucasian populationJulien Wipff, Philippe Dieude, Jerome Avouac, et al.
Joint Bone Spine|March 26, 2026
Clinical and Pharmacological Outcomes After Switching from Intravenous to Subcutaneous Infliximab in Chronic Inflammatory Rheumatic DiseasesOlivier Fogel, Cécile Bottois, Marie Laure Tourneur, et al.
Pageof 6